Clinical Trials Directory

Trials / Completed

CompletedNCT01848535

Effect of GOS Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults

Effect of Galacto-Oligosaccharides Supplementation on Amoxicillin-treated Gut Microbiota From Healthy Adults : a Proof of Principal Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Wageningen University · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Prebiotics are thought to be a potential means to prevent antibiotic-associated diarrhoea because of their ability to stimulate beneficial bacteria. In-vitro results showed a promising recovery of Bifidobacteria combined with an increase of Short Chain Fatty Acids (SCFA) upon Galacto-oligosaccharides (GOS) supplementation to amoxicillin-treated microbiota. As the microbiota is nowadays considered as a key factor in human health, a further understanding of the gut microbiota functioning in-vivo is essential. This understanding of the use of specific prebiotics may possibly be beneficial in the prevention or recovery of antibiotic-disturbed microbiota. As the effects of GOS supplementation on the microbiota composition and activity from healthy adults receiving amoxicillin have never been tested in-vivo, the investigators propose the current study as a proof of principle. Objective: To explore whether the promising effects of GOS supplementation on the composition and activity of gut microbiota from healthy adults as found by in-vitro, can also be observed in-vivo. Study population: 10 healthy men and women volunteers, 18 - 40 yr old

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGOS additionGOS (2.5g 3x per day) supplemented during 12 days
DIETARY_SUPPLEMENTPlaceboMaltodextrine(2.5g 3x per day) supplemented during 12 days

Timeline

Start date
2013-05-01
Primary completion
2013-07-01
Completion
2013-07-01
First posted
2013-05-07
Last updated
2013-11-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01848535. Inclusion in this directory is not an endorsement.